Pharmacological Agents and Compounding of Intrathecal Drugs

[1]  V. Granados-Soto,et al.  Role of opioid receptors in the reduction of formalin-induced secondary allodynia and hyperalgesia in rats. , 2009, European journal of pharmacology.

[2]  L. Terenius.  Characteristics of the "receptor" for narcotic analgesics in synaptic plasma membrane fraction from rat brain. , 2009, Acta pharmacologica et toxicologica.

[3]  K. Ho,et al.  Use of Intrathecal Midazolam to Improve Perioperative Analgesia: A Meta-Analysis , 2008, Anaesthesia and intensive care.

[4]  R. Coffey,et al.  Intrathecal baclofen and catheter tip inflammatory mass lesions (granulomas): a reevaluation of case reports and imaging findings in light of experimental, clinicopathological, and radiological evidence. , 2008, Pain medicine.

[5]  Howard S. Smith,et al.  Intrathecal drug delivery. , 2008, Pain physician.

[6]  S. Hassenbusch,et al.  Polyanalgesic Consensus Conference 2007: Recommendations for the Management of Pain by Intrathecal (Intraspinal) Drug Delivery: Report of an Interdisciplinary Expert Panel , 2007, Neuromodulation : journal of the International Neuromodulation Society.

[7]  R. Radhakrishnan,et al.  (675): Spinal release of acetylcholine in response to morphine , 2007 .

[8]  X. Ruan.  Drug-related side effects of long-term intrathecal morphine therapy. , 2007, Pain physician.

[9]  L. Webster,et al.  A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain. , 2006, Journal of pain and symptom management.

[10]  Gerhard Friehs,et al.  Intrathecal drug delivery for the management of cancer pain: a multidisciplinary consensus of best clinical practices. , 2005, The journal of supportive oncology.

[11]  P. Staats,et al.  An implantable drug delivery system (IDDS) for refractory cancer pain provides sustained pain control, less drug-related toxicity, and possibly better survival compared with comprehensive medical management (CMM). , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  Miljanich Gp,et al.  Ziconotide: neuronal calcium channel blocker for treating severe chronic pain. , 2004, Current medicinal chemistry.

[13]  E. Buchser,et al.  Efficacy of intrathecal bupivacaine: how important is the flow rate? , 2004, Pain medicine.

[14]  E. Kravitz,et al.  Intrathecal opioid treatment for chronic non-malignant pain: a 3-year prospective study , 2004, Pain.

[15]  M. Byas-Smith,et al.  Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial. , 2004, JAMA.

[16]  F. Lenz,et al.  Attenuation of cerebellar tremor with implantation of an intrathecal baclofen pump: the role of gamma-aminobutyric acidergic pathways. Case report. , 2003, Journal of neurosurgery.

[17]  R. Rauck,et al.  Long-term intrathecal opioid therapy with a patient-activated, implanted delivery system for the treatment of refractory cancer pain. , 2003, Journal of Pain.

[18]  T. Sakabe,et al.  A Comparison of the Neurotoxic Effects on the Spinal Cord of Tetracaine, Lidocaine, Bupivacaine, and Ropivacaine Administered Intrathecally in Rabbits , 2003, Anesthesia and analgesia.

[19]  S. Hassenbusch,et al.  Safety of Chronic Intrathecal Morphine Infusion in a Sheep Model , 2003, Anesthesiology.

[20]  C. Sommer,et al.  Chronically Infused Intrathecal Morphine in Dogs , 2003, Anesthesiology.

[21]  S. Hassenbusch,et al.  Inflammatory masses associated with intrathecal drug infusion: a review of preclinical evidence and human data. , 2002, Pain medicine.

[22]  S. Hassenbusch,et al.  Intrathecal Bupivacaine for Chronic Pain: A Review of Current Knowledge , 2002, Neuromodulation : journal of the International Neuromodulation Society.

[23]  V. C. Anderson,et al.  Stability and compatibility of hydromorphone hydrochloride in an implantable infusion system. , 2001, Journal of pain and symptom management.

[24]  K. Burchiel,et al.  Intrathecal hydromorphone for chronic nonmalignant pain: a retrospective study. , 2001, Pain medicine.

[25]  R. Coffey,et al.  Inflammatory Mass Lesions Associated with Intrathecal Drug Infusion Catheters: Report and Observations on 41 Patients , 2001, Neurosurgery.

[26]  M. Kelly,et al.  Continuous intrathecal morphine treatment for chronic pain of nonmalignant etiology: long-term benefits and efficacy. , 2001, Surgical neurology.

[27]  S. Hassenbusch,et al.  Evidence-based review of the literature on intrathecal delivery of pain medication. , 2000, Journal of pain and symptom management.

[28]  S. Abram,et al.  Intrathecal baclofen is analgesic in patients with chronic pain. , 2000, Anesthesiology.

[29]  K J Burchiel,et al.  A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain. , 1999, Neurosurgery.

[30]  D. Fitzgibbon,et al.  The control of severe cancer pain by continuous intrathecal infusion and patient controlled intrathecal analgesia with morphine, bupivacaine and clonidine , 1998, Pain.

[31]  J. Eisenach,et al.  Intrathecal, but Not Intravenous, Clonidine Reduces Experimental Thermal or Capsaicin-Induced Pain and Hyperalgesia in Normal Volunteers , 1998, Anesthesia and analgesia.

[32]  A. Aldrete.  Extended Epidural Catheter Infusions With Analgesics for Patients With Noncancer Pain at Their Homes , 1997, Regional Anesthesia & Pain Medicine.

[33]  J. Middleton,et al.  Intrathecal clonidine and baclofen in the management of spasticity and neuropathic pain following spinal cord injury: a case study. , 1996, Archives of physical medicine and rehabilitation.

[34]  R. Etches,et al.  Patient-Controlled Epidural Analgesia After Thoracotomy: A Comparison of Meperidine With and Without Bupivacaine , 1996, Anesthesia and analgesia.

[35]  H. Krijnen,et al.  Long-term intrathecal administration of midazolam and clonidine. , 1996, The Clinical journal of pain.

[36]  M. Chaney.  Side effects of intrathecal and epidural opioids , 1995, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[37]  S. Rutkowski,et al.  Intrathecal morphine and clonidine in the management of spinal cord injury pain: a case report , 1994, Pain.

[38]  B. Crul,et al.  Long-term intrathecal infusion of morphine and morphine/bupivacaine mixtures in the treatment of cancer pain: A retrospective analysis of 51 cases , 1993, Pain.

[39]  R. Penn,et al.  Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. , 1993, Journal of neurosurgery.

[40]  S. D'Luzansky,et al.  Intrathecal baclofen suppresses central pain in patients with spinal lesions. A pilot study. , 1992, The Clinical journal of pain.

[41]  J. Motsch,et al.  [Continuous intrathecal opiate therapy with a portable drug pump in cancer pain]. , 1988, Anasthesie, Intensivtherapie, Notfallmedizin.

[42]  R. Penn,et al.  The Effect of Chronic Subarachnoid Bupivacaine Infusion in Dogs , 1987, Anesthesiology.

[43]  F. Brescia.  An overview of pain and symptom management in advanced cancer. , 1987, Journal of pain and symptom management.

[44]  W R Gray,et al.  Peptide neurotoxins from fish-hunting cone snails. , 1985, Science.

[45]  M. Bahar,et al.  NEUROLOGICAL TOXICITY OF THE SUBARACHNOID INFUSION OF BUPIVACAINE, LIGNOCAINE OR 2-CHLOROPROCAINE IN THE RAT , 1985 .

[46]  T. Burks,et al.  Spinal cord-mediated opiate effects on gastrointestinal transit in mice. , 1982, European journal of pharmacology.

[47]  M. Chauvin,et al.  Plasma pharmacokinetics of morphine after i.m., extradural and intrathecal administration. , 1982, British journal of anaesthesia.

[48]  T. Yaksh,et al.  Analgesia mediated by a direct spinal action of narcotics. , 1976, Science.

[49]  S. D. Du Pen,et al.  Intrathecal hydromorphone for intractable nonmalignant pain: a retrospective study. , 2006, Pain medicine.

[50]  E. Krames.  Intrathecal infusional therapies for intractable pain: patient management guidelines. , 1993, Journal of pain and symptom management.